In vitro enhancement of antitumor activity of a water-soluble duocarmycin derivative, KW-2189, by caffeine-mediated DNA-repair inhibition in human lung cancer cells
- PMID: 9439677
- PMCID: PMC5921316
- DOI: 10.1111/j.1349-7006.1997.tb00326.x
In vitro enhancement of antitumor activity of a water-soluble duocarmycin derivative, KW-2189, by caffeine-mediated DNA-repair inhibition in human lung cancer cells
Abstract
Duocarmycins, including KW-2189, bind in the minor groove of double-stranded DNA at A-T-rich sequences, followed by covalent bonding with N-3 of adenine in preferred sequences. We examined the effect of DNA-repair modulators, such as caffeine and aphidicolin, on the cytotoxicity of duocarmycins towards human lung cancer cells, as determined by dye formation assay. Caffeine (0.5 or 1 mM), but not aphidicolin, enhanced the growth-inhibitory activity of KW-2189, DU-86, and duocarmycin SA. Caffeine inhibited repair of DNA strand breaks induced by KW-2189, as assayed by the alkaline elution technique. This suggests that duocarmycin-induced DNA strand breaks, which are potentially lethal to cells, are repaired through a caffeine-sensitive pathway.
Similar articles
-
A novel antitumor antibiotic, KW-2189 is activated by carboxyl esterase and induces DNA strand breaks in human small cell lung cancer cells.Jpn J Cancer Res. 1994 Apr;85(4):418-25. doi: 10.1111/j.1349-7006.1994.tb02375.x. Jpn J Cancer Res. 1994. PMID: 8200853 Free PMC article.
-
Characteristics of antitumor activity of KW-2189, a novel water-soluble derivative of duocarmycin, against murine and human tumors.Cancer Res. 1994 May 1;54(9):2404-10. Cancer Res. 1994. PMID: 8162588
-
Intracellular carboxyl esterase activity is a determinant of cellular sensitivity to the antineoplastic agent KW-2189 in cell lines resistant to cisplatin and CPT-11.Jpn J Cancer Res. 1995 Jan;86(1):124-9. doi: 10.1111/j.1349-7006.1995.tb02997.x. Jpn J Cancer Res. 1995. PMID: 7737904 Free PMC article.
-
Pharmacogenomics of platinum-based chemotherapy in non-small cell lung cancer: focusing on DNA repair systems.Med Oncol. 2017 Apr;34(4):48. doi: 10.1007/s12032-017-0905-6. Epub 2017 Feb 18. Med Oncol. 2017. PMID: 28215024 Review.
-
Pharmacogenetics of platinum-based chemotherapy in non-small cell lung cancer: predictive validity of polymorphisms of ERCC1.Expert Opin Drug Metab Toxicol. 2018 Jan;14(1):17-24. doi: 10.1080/17425255.2018.1416095. Epub 2017 Dec 18. Expert Opin Drug Metab Toxicol. 2018. PMID: 29226731 Review.
Cited by
-
Circulating metabolite profiles to predict overall survival in advanced non-small cell lung cancer patients receiving first-line chemotherapy.Lung Cancer. 2017 Dec;114:70-78. doi: 10.1016/j.lungcan.2017.10.018. Epub 2017 Nov 2. Lung Cancer. 2017. PMID: 29173770 Free PMC article.
-
Causal role of metabolites in non-small cell lung cancer: Mendelian randomization (MR) study.PLoS One. 2024 Mar 22;19(3):e0300904. doi: 10.1371/journal.pone.0300904. eCollection 2024. PLoS One. 2024. PMID: 38517880 Free PMC article.
References
-
- ) Kobayashi , E. , Okamoto , A. , Asada , M. , Okabe , M. , Nagamura , S. , Asai , A. , Saito , H. , Gomi , K. and Hirata , T.Characteristics of antitumor activity of KW‐2189, a novel water‐soluble derivative of duocarmycin, against murine and human tumors . Cancer Res. , 54 , 2404 – 2410 ( 1994. ). - PubMed
-
- ) Ogasawara , H. , Nishio , K. , Takeda , Y. , Ohmori , T. , Kubota , N. , Funayama , Y. , Ohira , T. , Kuraishi , Y. , Isogai , Y. and Saijo , N.A novel antitumor antibiotic, KW‐2189 is activated by carboxyl esterase and induces DNA strand breaks in human small cell lung cancer cells . Jpn. J. Cancer Res. , 85 , 418 – 425 ( 1994. ). - PMC - PubMed
-
- ) Ogasawara , H. , Nishio , K. , Kanzawa , P. , Lee , Y.‐S. , Funayama , Y. , Ohira , T. , Kuraishi , Y. , Isogai , Y. and Saijo , N.Intracellular carboxyl esterase activity is a determinant of cellular sensitivity to the antineoplastic agent KW‐2189 in cell lines resistant to cisplatin and CPT‐11 . Jpn. J. Cancer Res. , 86 , 124 – 129 ( 1995. ). - PMC - PubMed
-
- ) Boger , D. L. , Ishizaki , T. and Zarrinmayeh , H , Synthesis and preliminary evaluation of agents incorporating the pharmacophore of the duocarmycin/pyrindamycin alkylation subunit: identification of the CC‐1065/duocarmycin common pharmacophore . J. Org. Chem. , 55 , 4499 – 4502 ( 1990. ).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical